We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.05B
AUM Growth
+$54.3M
Cap. Flow
-$70M
Cap. Flow %
-1.73%
Top 10 Hldgs %
10.14%
Holding
326
New
22
Increased
54
Reduced
163
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 21.3%
2 Healthcare 18.83%
3 Financials 14.97%
4 Industrials 14.07%
5 Consumer Discretionary 12.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTZ icon
126
MasTec
MTZ
$21.9B
$14.3M 0.35%
277,354
-1,433
-0.5% -$70.8K
GLOG
127
DELISTED
GASLOG LTD
GLOG
$14M 0.35%
975,132
-2,938
-0.3% -$44.4K
DOOR
128
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$13.6M 0.33%
257,246
-673
-0.3% -$34.8K
IRWD icon
129
Ironwood Pharmaceuticals
IRWD
$714M
$13.5M 0.33%
+1,232,782
New +$13.8M
GTES icon
130
Gates Industrial Corporation Ltd.
GTES
$7.15B
$13.5M 0.33%
1,180,245
-2,478
-0.2% -$33.3K
DY icon
131
Dycom Industries
DY
$12.3B
$13.3M 0.33%
225,115
+51,561
+30% +$2.64M
ENR icon
132
Energizer
ENR
$1.55B
$13.2M 0.33%
342,564
-747
-0.2% -$33.4K
PCRX icon
133
Pacira BioSciences
PCRX
$997M
$13M 0.32%
298,761
+56,733
+23% +$2.41M
NVCR icon
134
NovoCure
NVCR
$1.91B
$12.8M 0.32%
202,617
-23,088
-10% -$1.17M
PTLA
135
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12.6M 0.31%
464,465
+37,157
+9% +$1.17M
TFIN icon
136
Triumph Financial Inc
TFIN
$1.82B
$12.5M 0.31%
431,093
-884
-0.2% -$26.4K
AXGN icon
137
Axogen
AXGN
$2.5B
$12.5M 0.31%
630,197
+159,430
+34% +$3.41M
CERS icon
138
Cerus
CERS
$474M
$12.3M 0.3%
2,194,628
+259,932
+13% +$1.44M
IONS icon
139
Ionis Pharmaceuticals
IONS
$9.4B
$12.1M 0.3%
187,561
-1,527
-0.8% -$108K
CCS icon
140
Century Communities
CCS
$2.03B
$11.6M 0.29%
437,222
-2,265
-0.5% -$60K
WGO icon
141
Winnebago Industries
WGO
$909M
$11.5M 0.28%
297,450
-1,528
-0.5% -$53.8K
OPLN
142
Openlane
OPLN
$4.54B
$11.4M 0.28%
454,851
-749,066
-62% -$16.1M
KN icon
143
Knowles
KN
$3.34B
$11.1M 0.27%
606,538
-3,114
-0.5% -$54.9K
BNFT
144
DELISTED
Benefitfocus, Inc.
BNFT
$10.9M 0.27%
402,974
+35,467
+10% +$1.19M
INGN icon
145
Inogen
INGN
$164M
$10.9M 0.27%
162,844
-45,483
-22% -$3.46M
WTTR icon
146
Select Water Solutions
WTTR
$2.61B
$10.7M 0.26%
919,811
-4,758
-0.5% -$55.5K
SRI icon
147
Stoneridge
SRI
$213M
$10.5M 0.26%
333,367
-1,725
-0.5% -$51K
VCRA
148
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$10.5M 0.26%
328,925
-844
-0.3% -$26.9K
UCTT
149
Ultra Clean Holdings
UCTT
$3.95B
$10.4M 0.26%
745,459
-3,829
-0.5% -$48.8K
ICPT
150
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.3M 0.25%
129,346
+17,259
+15% +$1.54M

Similar funds

Peregrine Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Peregrine Capital Management held 326 positions worth $4.05B, up 1.4% from $4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Peregrine Capital Management's Q2 2019 filing shows 22 new, 54 increased, 163 reduced and 21 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 361,870 shares worth $21.8M. The largest sale was Cadence Design Systems, an estimated $26.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q2 2019 buy was Black Knight, Inc. Common Stock: 361,870 shares worth $21.8M.
  • Peregrine Capital Management added most to HealthEquity in Q2 2019, an estimated $18.3M increase.
  • Peregrine Capital Management's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $26.3M.
  • Peregrine Capital Management fully exited Cadence Design Systems in Q2 2019, selling an estimated $26.6M.
  • Peregrine Capital Management's ten largest holdings make up 10% of its $4.05B portfolio in Q2 2019.
  • Peregrine Capital Management opened 22 new positions and closed 21 in Q2 2019.
  • Peregrine Capital Management's portfolio value rose 1.4% quarter-over-quarter to $4.05B.

Based on Peregrine Capital Management's 13F filing for Q2 2019, filed 18 Jul 2019.